Medical Advocates
HCV Infection/Disease
  Management

General Reports                     Non-Responders              
Directly Observed Therapy     Liver Transplantation
Screening                               Lung Transplantation
Pretreatment                          Kidney Transplantation
 Drugs                                      Adverse Events
Adherence                              Alternative Therapies
Mental Health
Nutrition/Weight Management
Fatigue/Anemia
Acute Hepatitis
 Recurrent Hepatitis
Chronic Hepatitis
HCV/HBV Coinfection
HCV Main Page Main New/Newsworthy   Home Page    
Last Update:  July 10, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
 
     Journal Papers, Abstracts, and Commentaries
 
 
FULL TEXT ARTICLE
Extended-therapy duration for chronic hepatitis C, genotype 1: The long and the short of it.
 Pearlman BL
World J Gastroenterol. 2008 Jun 21;14(23):3621-7
 Paper
 
Treatment of chronic viral hepatitis
 Pedersen C, Pedersen CR.
Ugeskr Laeger. 2008 Jun 9;170(24):2137-40.
 Abstract
 
Evaluation of the French national plan to promote screening and early management of viral
hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes
region.
 Defossez G, Verneau A, Ingrand I, et al
Eur J Gastroenterol Hepatol. 2008 May;20(5):367-372.
Abstract
 
Treatment regimens for patients with chronic hepatitis C.
 Trapero-Marugan M, González-Moreno L, Chaparro-Sánchez M, et al
 Minerva Gastroenterol Dietol. 2008 Jun;54(2):209-17
 Abstract
 
Hepatitis C for addiction professionals
 Sylvestre D.  
Addict Sci Clin Pract. 2007 Dec;4(1):34-41
 Abstract
 
Targeting lipid metabolism in the treatment of hepatitis C virus infection.
 Amemiya F, Maekawa S, Itakura Y, et al   
J Infect Dis. 2008 Feb 1;197(3):361-70
 Abstract
 
How Physicians Describe Outcomes to HCV Therapy: Prevalence and Meaning of "Cure" During
Provider-Patient In-office Discussions of HCV.
 Hamilton HE, Gordon C, Nelson M, et al 
J Clin Gastroenterol. 20
Abstract
 
ARTICLE
 Making it happen: managed care considerations in vanquishing hepatitis C.
McHutchison JG, Bacon BR, Owens GS. et al 
Am J Manag Care. 2007 Dec;13 Suppl 12:S327-36;
Paper
 
An introduction of the consensus statements on the diagnosis, management and treatment of
hepatitis C virus infection from the Asian Pacific Association for the Study of the Liver.
 Li L, Fan HB, Yang DL.
Zhonghua Gan Zang Bing Za Zhi. 2007 Dec;15(12):955-7.
 Abstract
 
Inflammation and Repair in Viral Hepatitis C.
 Neuman MG, Sha K, Esguerra R, et al 
Dig Dis Sci. 2007 Nov 10;
 Abstract
 
Improved cognitive function as a consequence of hepatitis C virus treatment.
Thein H, Maruff P, Krahn M, et al
HIV Med. 2007 Nov;8(8):520-8
 Abstract
 
FULL TEXT ARTICLE
Specifically targeted antiviral therapy for hepatitis C virus.
 Parfieniuk A, Jaroszewicz J, Flisiak R, et al  
World J Gastroenterol. 2007 Nov 21;13(43):5673-81.
 Paper
 
FULL TEXT ARTICLE
 Clinical significance of activity of ALT enzyme in patients with hepatitis C virus.
 Akkaya O, Kiyici M, Yilmaz Y, et al
World J Gastroenterol. 2007 Nov 7;13(41):5481-5.
 Paper
 
Treatment uptake and outcomes among current and former injection drug users receiving
directly observed therapy within a multidisciplinary group model for the treatment of hepatitis
C virus infection.
 Grebely J, Genoway K, Khara M, et al
Int J Drug Policy. 2007 Oct;18(5):437-43.
 Abstract
 
Integrating multiple programme and policy approaches to hepatitis C prevention and care for
injection drug users: a comprehensive approach.
Birkhead GS, Klein SJ, Candelas AR, et al  
Int J Drug Policy. 2007 Oct;18(5):417-25
 Abstract
 
Improving access to HCV treatment: external jugular venepuncture can overcome problems
with difficult venous access.
Mason S, Watts A, Sheils S, Koorey D.
Int J Drug Policy. 2007 Oct;18(5):433-6.
 Abstract
 
A Preliminary Comparison of Major Kinds of Obstacles to Enrolling in Substance Abuse Treatment
(AOD) Reported by Injecting Street Outreach Clients and Other Stakeholders.
Appel PW, Oldak R.
Am J Drug Alcohol Abuse. 2007;33(5):699-705.
Abstract
 
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of
liver-related complications.
 Pradat P, Tillmann HL, Sauleda S, et al 
J Viral Hepat. 2007 Aug;14(8):556-63
 Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL TEXT ARTICLE
 Hepatitis C virus: Virology, diagnosis and management of antiviral therapy.
 Chevaliez S, Pawlotsky JM.
World J Gastroenterol. 2007 May 7;13(17):2461-6
 Paper
 
A Systematic Review of Provider Knowledge of Hepatitis C: Is it Enough for a Complex
Disease?
 Zickmund SL, Brown KE, Bielefeldt K.
 Dig Dis Sci. 2007 Apr 4;
 Abstract
 
Treatment of hepatitis C virus infection.
 Weigand K, Stremmel W, Encke J  
World J Gastroenterol. 2007 Apr 7;13(13):1897-905
 Abstract
 
Short-duration therapy for hepatitis C: suitable for all?
 Mangia A.
J Viral Hepat. 2007 Apr;14(4):221-7.
 Abstract
 
Hepatitis C management by addiction medicine physicians: Results from a national survey.
 Litwin AH, Kunins HV, Berg KM, et al
J Subst Abuse Treat. 2007 Mar 20
 Abstract
 
New paradigms in the management of hepatitis C virus co-infections.
 Sherman KE.  
Nat Clin Pract Gastroenterol Hepatol. 2007 Jan;4 Suppl 1:S10-6.
 Abstract
 
Medical care and alcohol use after testing hepatitis C antibody positive at STD clinic
and HIV test site screening programs.
 Mark KE, Murray PJ, Callahan DB, Gunn RA.
Public Health Rep. 2007 Jan-Feb;122(1):37-43.
 Abstract
 
Short-term treatment duration for HCV-2 and HCV-3 infected patients.
 Andriulli A, Dalgard O, Bjoro K, Mangia A.  
Dig Liver Dis. 2006 Aug 14
 Abstract
 
FULL-TEXT ARTICLE
Advances in Managing Hepatitis C Virus (HCV) Infection
Hu KQ.  
Int J Med Sci. 2006;3(2):28.
 Paper
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
 A practical approach to managing patients with HCV infection.
 Huang RH, Hu KQ. 
Int J Med Sci. 2006;3(2):63-8.
 Paper
 
Comparison of characteristics of treated and non-treated patients with Hepatitis C infection.
 Hare CB, Morris JA, Chu A, Gotz V, rt al
Pharmacoepidemiol Drug Saf. 2005 Sep 1;
Abstract
 
Treatment of hepatitis C: critical appraisal of the evidence.
 Camma C, Licata A, Cabibbo G, et al 
Expert Opin Pharmacother. 2005 Mar;6(3):399-408.
Abstract
 
Prospective study in 142 cases of hepatitis C virus infection.
 Fan WM, Zhu WF, Yin LM, et al
World J Gastroenterol. 2004 Oct 1;10(19):2867-9
 Abstract
 
Hepatitis C treatment update.
 Pearlman BL. 
Am J Med. 2004 Sep 1;117(5):344-5
 Abstract
 
The impact of hepatitis C status on postoperative outcome.
Cheung RC, Hsieh F, Wang Y, Pollard JB.
Anesth Analg. 2003 Aug;97(2):550-4.
 Abstract

Hepatitis C virus clearance: the enigma of failure despite an impeccable survival strategy.
 Isaguliants MG.
Curr Pharm Biotechnol 2003 Jun;4(3):169-83
 Abstract

Optimal therapy of hepatitis C.
Di Bisceglie AM, Hoofnagle JH.
Hepatology 2002 Nov;36(5 Suppl 1):S121-7
 Abstract

Side effects of therapy of hepatitis C and their management.
Fried MW.
Hepatology 2002 Nov;36(5 Suppl 1):S237-44
Abstract

Prevalence and clinical features of skin diseases in chronic HCV infection.
A prospective study in 96 patients.
Paoletti V, Mammarella A, Basili S, et al.
Panminerva Med 2002 Dec;44(4):349-52
 Abstract

  
Directly Observed Therapy
 
    Journal Papers, Abstracts, and Commentaries
 
  Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection
drug users.
 Grebely J, Raffa JD, Meagher C, et al  J Gastroenterol Hepatol. 2007 Jul 20;
Abstract
Screening
 
    Journal Papers, Abstracts, and Commentaries
 
  Is screening for interferon retinopathy in hepatitis C justified?
 Cuthbertson FM, Davies M, McKibbin M. 
Br J Ophthalmol. 2004 Dec;88(12):1518-1520.
 Abstract
 
     Conference Reports, Abstracts, and Posters
 
  Importance of screening colonoscopy among patients with hcv related liver disease
Chaparala H., Gurakar A., Wright H.,, et al
(Conference Citations from the 12th International Symposium on Viral Hepatitis and Liver Disease)
 Abstract
Pretreatment
 
    Journal Papers, Abstracts, and Commentaries
 
  Pretreatment sequence diversity differences in the full-length Hepatitis C Virus open reading
frame correlate with early response to therapy.
 Donlin MJ, Cannon NA, Yao E, et al
J Virol. 2007 May 23;
 Abstract
Adherence to Drug Therapy
 
    Journal Papers, Abstracts, and Commentaries
 
 
The effect of adherence to therapy on sustained response in daily or three times a week "
interferon alpha-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis C
patients.
Raptopoulou M, Tsantoulas D, Vafiadi I, et al 
J Viral Hepat. 2005 Jan;12(1):91-5
 Abstract
 
Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C.
Mulhall BP, Younossi Z.
J Clin Gastroenterol. 2005 Jan;39(1 Suppl):S23-7
 Abstract

Adherence to combination therapy: influence on sustained virologic response and
economic mpact.
Manns MP.
 Gastroenterol Clin North Am. 2004 Mar;33(1 Suppl):S11-24.
 Abstract
 
Adherence to combination therapy enhances sustained response in genotype-1-
infected patients with chronic hepatitis C.
 McHutchison JG, Manns M, Patel K, et al.
Gastroenterology 2002 Oct;123(4):1061-9
 Abstract

Mental Health Care
 
    Journal Papers, Abstracts, and Commentaries
 
 
Gastroenterologists' perceptions of need and availability of psychiatric services for patients
with hepatitis C.
 Gleason O, Fucci J, Yates W.
Psychosomatics. 2008 Mar-Apr;49(2):132-6.
 Abstract

Integrated psychiatric/medical care in a chronic hepatitis C clinic: effect on antiviral
treatment evaluation and outcomes.
Knott A, Dieperink E, Willenbring ML, et al
 Am J Gastroenterol. 2006 Oct;101(10):2254-62.
 Abstract
Nutrition/Weight Management
 
     Journal Papers, Abstracts, and Commentaries
 
 
Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in
patients with chronic hepatitis C virus.
Iwasa M, Iwata K, Kaito M, et al
Nutrition. 2004 Apr;20(4):368-71
 Abstract
 
Modest weight loss and physical activity in overweight patients with chronic liver
disease results in sustained improvements in alanine aminotransferase, fasting insulin,
and quality of life.
 Hickman IJ, Jonsson JR, Prins JB, et al 
Gut. 2004 Mar;53(3):413-419.
 Abstract
 
FULL-TEXT ARTICLE
Hepatitis C: Nutrition Care Canadian Guidelines for Health Care Providers.
 Can J Diet Pract Res. 2003 Autumn;64(3):139-141
 Paper
Fatigue/Anemia
 

     Journal Papers, Abstracts, and Commentaries

 
Use of erythropoietin in the treatment of anemia induced by ribavirin/interferon in patients
with hepatitis C
Lunel-Fabiani F, Fouchard-Hubert I, Gergely AE.
Pathol Biol (Paris). 2003 Oct;51(8-9):520-4.
 Abstract

The experience of fatigue for people living with hepatitis C.
Glacken M, Coates V, Kernohan G, Hegarty J.
J Clin Nurs 2003 Mar;12(2):244-52
 Abstract

Fatigue in patients with chronic hepatitis C.
 Poynard T, Cacoub P, Ratziu V, et al.
 J Viral Hepat 2002 Jul;9(4):295-303
 Abstract

Fatigue, depression and chronic hepatitis C infection.
 Wessely S, Pariante C.
 Psychol Med 2002 Jan;32(1):1-10/
 Abstract
 
Assessment of fatigue and psychologic disturbances in patients with hepatitis C virus
infection.
 Obhrai J, Hall Y, Anand BS.
J Clin Gastroenterol 2001 May-Jun;32(5):413-7
 Abstract
 
Acute Hepatitis
 

     Journal Papers, Abstracts, and Commentaries

 
Outcomes and Treatment of Acute Hepatitis C Virus Infection in a United States Population.
 Corey KE, Ross AS, Wurcel A, et al  
Clin Gastroenterol Hepatol. 2006 Aug 21;
 Abstract

Therapy of acute hepatitis C.
Alberti A, Boccato S, Vario A, Benvegnu L.
Hepatology 2002 Nov;36(5 Suppl 1):S195-200
 Abstract

Management strategies using pharmacogenomics in patients with severe HCV-1b infection:
A decision analysis.
Moriguchi H, Uemura T, Kobayashi M, et al.
Hepatology 2002 Jul;36(1):177-185
 Abstract

FULL-TEXT ARTICLE
ABC of diseases of liver, pancreas, and biliary system: Acute hepatitis
Ryder SD,  Beckingham IJ
 BMJ 2001; 322: 151-153.
Paper

  

     Conference Reports, Abstracts, and Posters

 

Draft NIH Consensus Statement on the Management of Hepatitis C
 [NIH Consensus Development Conference on  Management of Hepatitis C: 2002 ]
 Report

PRESENTATION
Patients With Normal ALT Levels
 Bacon BR
 [NIH Consensus Development Conference on  Management of Hepatitis C: 2002 ]
 Report

PRESENTATION
Therapy of Acute Hepatitis C
 Alberti A
[NIH Consensus Development Conference on  Management of Hepatitis C: 2002 ]
 Report

PRESENTATION
Side Effects of Therapy and Management
 Fried MW
[NIH Consensus Development Conference on  Management of Hepatitis C: 2002 ]
 Report

Recurrent Hepatitis
Post-Transplant HCV Recurrence

     Journal Papers, Abstracts, and Commentaries

 
How can we identify better those with recurrent hepatitis C who will respond to therapy?
What are the optimal treatment regimen and treatment duration?
 Wright TL.
 Liver Transpl. 2003 Nov;9(11):S109-13.
 Abstract

Treatment of recurrent hepatitis C.
 Gane E
Liver Transpl 2002 Oct;8(10 Suppl 1):S28-37
 Abstract

  
Chronic Hepatitis
 

     Journal Papers, Abstracts, and Commentaries        

 
Rapid virologic response: a new milestone in the management of chronic hepatitis C
 Poordad F, Reddy KR, Martin P.
Clin Infect Dis. 2008 Jan 1;46(1):78-84
 Abstract
 
Predictors of treatment in patients with chronic hepatitis C infection-Role of patient versus
nonpatient factors.
 Kanwal F, Hoang T, Spiegel BM, et al
Hepatology. 2007 Nov 28;46(6):1741-1749
 Abstract
 
Personalized therapy for chronic viral hepatitis C in the naive patient: How can we optimize
treatment duration as a function of viral genotype?
 Nguyen-Khac E, Capron D, Castelain S, et al
 Eur J Intern Med. 2007 Nov;18(7):510-5.
 Abstract
 
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment
with the'accordion' regimen?
 Marcellin P, Heathcote EJ, Craxì A.
J Hepatol. 2007 Oct;47(4):580-587.
 Abstract
 
Chronic hepatitis C virus infection: A review for pharmacists.
 Rodis J.
J Am Pharm Assoc (2003). 2007 Jul-Aug;47(4)
 Abstract
 
Maintenance therapy for chronic hepatitis C.
 Trépo C, Marion-Audibert AM, Samuel D, Guyader D, Fontanges T.
 Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 3):29-33.
Abstract
 
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection.
Westin J, Ydreborg M, Islam S, et al
Scand J Gastroenterol. 2007 Sep 18;:1-8
Abstract
 
Response prediction and treatment tailoring in chronic hepatitis C virus genotype 1 infection.
 Lindh M, Alestig E, Arnholm B, et al 
J Clin Microbiol. 2007 Jun 20;
Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
Reasons Why Patients Infected with Chronic Hepatitis C Virus Choose to Defer Treatment: Do
They Alter Their Decision with Time?
 Khokhar OS, Lewis JH
Dig Dis Sci. 2007 Mar 15;
 Abstract
 
Customizing treatment to patient populations.
 Brown RS Jr.
Nat Clin Pract Gastroenterol Hepatol. 2007 Jan;4 Suppl 1:S3-9.
 Abstract
 
Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons
from the HALT-C trial.
 Everson GT, Hoefs JC, Seeff LB, et al 
Hepatology. 2006 Dec;44(6):1675-84.
 Abstract
 
Review article: management of patients with chronic hepatitis C virus infection and 'normal'
alanine aminotransferase activity.
 Zeuzem S, Alberti A, Rosenberg W, et al 
Aliment Pharmacol Ther. 2006 Oct 15;24(8):1133-49.